Ozurdex, the first drug therapy for the treatment of macular oedema, following branch retinal vein
occlusion or central retinal vein occlusion, has been approved by the FDA.
A biological marker for neovascular age-related macular degeneration (AMD) has been discovered by a
team of researchers from the University of Kentucky.
The Outside Clinic Account Holders C18188 (VRICS) Problems in the Periphery
January 4th, 2012 ~ 0 Comments
The Outside Clinic Account Holders: Glaucoma detection for the domiciliary optometrist. Paper 2: Management C 17915 (O)
November 29th, 2011 ~ 0 Comments
The Outside Clinic Account Holders: C17314 (VRICS) Problems at the Pole
September 28th, 2011 ~ 0 Comments
The Outside Clinic Account Holders C18188 (VRICS) Problems in the Periphery
January 4th, 2012 ~ 0 Comments
The Outside Clinic Account Holders: Glaucoma detection for the domiciliary optometrist. Paper 2: Management C 17915 (O)
November 29th, 2011 ~ 0 Comments
The Outside Clinic Account Holders: C17314 (VRICS) Problems at the Pole
September 28th, 2011 ~ 0 Comments